Spire Wealth Management Seagen Inc. Transaction History

Spire Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$191.51 - $216.16 $766 - $864	4 Added 1.89%	216 $45,000
Q2 2023 Aug 09, 2023	SELL	$187.64 - $206.25 $2,251 - $2,475	-12 Reduced 5.36%	212 $40,000
Q4 2022 Feb 03, 2023	BUY	$117.37 - $139.17 $1,408 - $1,670	12 Added 5.66%	224 $29,000
Q3 2022 Nov 07, 2022	SELL	$135.27 - $180.11 $6,763 - $9,005	-50 Reduced 19.08%	212 $29,000
Q4 2021 Jan 14, 2022	SELL	$142.57 - $190.86 $7,128 - $9,543	-50 Reduced 16.03%	262 $41,000
Q1 2021 May 21, 2021	BUY	$137.51 - $190.8 $42,903 - $59,529	312 New	312 $43,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.